Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells

por Palanca-Wessels, Maria C., Booth, Garrett C., Convertine, Anthony J., Lundy, Brittany B., Berguig, Geoffrey Y., Press, Michael F., Stayton, Patrick S., Press, Oliver W.
Publicado 2016